FDA
approval
· 2017-05-26
FDA Approved: MORPHINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for Morphine Sulfate from Actavis Pharma, Inc., permitting continued marketing of the generic product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MORPHINE SULFATE (MORPHINE SULFATE)